| Year |
Citation |
Score |
| 2018 |
Cole JH, Caan MWA, Underwood J, De Francesco D, van Zoest RA, Wit FWNM, Mutsaerts HJMM, Leech R, Geurtsen GJ, Portegies P, Majoie CBLM, Schim van der Loeff MF, Sabin CA, Reiss P, Winston A, et al. No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29309532 DOI: 10.1093/Cid/Cix1124 |
0.381 |
|
| 2017 |
Van Zoest RA, Underwood J, De Francesco D, Sabin CA, Cole JH, Wit FW, Caan MWA, Kootstra NA, Fuchs D, Zetterberg H, Majoie CBLM, Portegies P, Winston A, Sharp DJ, Gisslén M, et al. Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers. The Journal of Infectious Diseases. PMID 29069436 DOI: 10.1093/Infdis/Jix553 |
0.462 |
|
| 2017 |
Underwood J, Cole JH, Caan M, De Francesco D, Leech R, van Zoest RA, Su T, Geurtsen GJ, Schmand BA, Portegies P, Prins M, Wit FW, Sabin CA, Majoie C, Reiss P, et al. Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28387814 DOI: 10.1093/Cid/Cix301 |
0.417 |
|
| 2017 |
Cole JH, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, et al. Increased brain-predicted aging in treated HIV disease. Neurology. PMID 28258081 DOI: 10.1212/Wnl.0000000000003790 |
0.419 |
|
| 2017 |
Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. Aids (London, England). PMID 28121708 DOI: 10.1097/Qad.0000000000001414 |
0.467 |
|
| 2016 |
Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART. Aids (London, England). PMID 27149087 DOI: 10.1097/Qad.0000000000001133 |
0.462 |
|
| 2016 |
Schouten J, Su T, Wit FW, Kootstra NA, Caan MW, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB, Portegies P, Reiss P. Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. Aids (London, England). PMID 26752277 DOI: 10.1097/Qad.0000000000001017 |
0.434 |
|
| 2016 |
Su T, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Cole JH, Sharp DJ, Vos FM, Prins M, Portegies P, Reiss P, Majoie CB. White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. Aids (London, England). 30: 311-22. PMID 26691551 DOI: 10.1097/Qad.0000000000000945 |
0.487 |
|
| 2015 |
Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. Aids (London, England). 29: 547-57. PMID 25587908 DOI: 10.1097/Qad.0000000000000573 |
0.438 |
|
| 2015 |
Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MWA, Reiss P, Majoie CB, Schmand BA. Novel method for more reliably estimating the burden of cognitive impairment in HIV Experimental Gerontology. 68: 103. DOI: 10.1016/J.Exger.2015.01.035 |
0.38 |
|
| 2015 |
Su T, Caan MWA, Wit FNWN, Schouten J, Geurtsen GJ, Schmand B, Vos F, Portegies P, Reiss P, Majoie CB. White matter abnormalities in males with suppressed HIV-infection on cart compared to representative controls Experimental Gerontology. 68: 97. DOI: 10.1016/J.Exger.2015.01.020 |
0.421 |
|
| 2014 |
Hoogland ICM, Portegies P. HIV-associated dementia: Prompt response to zidovudine. Neurology. Clinical Practice. 4: 263-265. PMID 29473585 DOI: 10.1212/CPJ.0000000000000035 |
0.338 |
|
| 2014 |
Hoogland ICM, Portegies P. HIV-associated dementia: Prompt response to zidovudine Neurology: Clinical Practice. 4: 263-265. DOI: 10.1212/CPJ.0000000000000035 |
0.338 |
|
| 2012 |
Bol SM, Booiman T, van Manen D, Bunnik EM, van Sighem AI, Sieberer M, Boeser-Nunnink B, de Wolf F, Schuitemaker H, Portegies P, Kootstra NA, van 't Wout AB. Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia. Plos One. 7: e30990. PMID 22347417 DOI: 10.1371/Journal.Pone.0030990 |
0.449 |
|
| 2011 |
Cornelissen M, Back NK, Burger DM, Blom P, Portegies P, Prins JM, van der Valk M. Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy. Antiviral Therapy. 16: 931-5. PMID 21900726 DOI: 10.3851/Imp1781 |
0.493 |
|
| 2011 |
Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. Aids (London, England). 25: 561-75. PMID 21160410 DOI: 10.1097/Qad.0B013E3283437F9A |
0.5 |
|
| 2010 |
Portegies P. HIV/HAART and the brain — what's going on? Journal of the International Aids Society. 13: O35-O35. DOI: 10.1186/1758-2652-13-S4-O35 |
0.308 |
|
| 2010 |
Portegies P, Cinque P, Chaudhuri A, Begovac J, Everall I, Weber T, Bojar M, Martinez-Martin P, Kennedy PGE. Neurological Complications of HIV Infection European Handbook of Neurological Management: Second Edition. 1: 373-381. DOI: 10.1002/9781444328394.ch24 |
0.367 |
|
| 2007 |
Portegies P, Berger JR. Introduction to HIV infection and neuro-AIDS. Handbook of Clinical Neurology. 85: 1-2. PMID 18808972 DOI: 10.1016/S0072-9752(07)85001-9 |
0.366 |
|
| 2004 |
Portegies P, Solod L, Cinque P, Chaudhuri A, Begovac J, Everall I, Weber T, Bojar M, Martinez-Martin P, Kennedy PG. Guidelines for the diagnosis and management of neurological complications of HIV infection. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 297-304. PMID 15142222 DOI: 10.1111/j.1468-1331.2004.00856.x |
0.393 |
|
| 2004 |
Stoff DM, Khalsa JH, Monjan A, Portegies P. Introduction: HIV/AIDS and Aging. Aids (London, England). 18: S1-2. PMID 15075491 DOI: 10.1097/00002030-200401001-00001 |
0.44 |
|
| 2001 |
Renwick N, Weverling GJ, Halaby T, Portegies P, Bakker M, Schulz TF, Goudsmit J. Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex. Aids (London, England). 15: 2165-9. PMID 11684936 DOI: 10.1097/00002030-200111090-00012 |
0.516 |
|
| 2001 |
Rosenberg NR, Portegies P, de Visser M, Vermeulen M. Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. Journal of Neurology, Neurosurgery, and Psychiatry. 71: 205-9. PMID 11459893 DOI: 10.1046/J.1529-8027.2002.2008_9.X |
0.352 |
|
| 2001 |
Foudraine NA, Jurriaans S, Weverling GJ, Burger DM, Hoetelmans RM, Roos MT, Maas J, Miedema F, Reiss P, Portegies P, de Wolf F, Lange JM. Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial. Antiviral Therapy. 6: 55-62. PMID 11417762 |
0.347 |
|
| 2001 |
Portegies P, Rosenberg NR. [Sensory neuropathy in HIV infection: pathogenesis and therapy]. Nederlands Tijdschrift Voor Geneeskunde. 145: 731-5. PMID 11332255 |
0.358 |
|
| 2001 |
Enting RH, Prins JM, Jurriaans S, Brinkman K, Portegies P, Lange JM. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 32: 1095-9. PMID 11264039 DOI: 10.1086/319602 |
0.449 |
|
| 2000 |
Gisolf EH, van Praag RM, Jurriaans S, Portegies P, Goudsmit J, Danner SA, Lange JM, Prins JM. Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 25: 426-33. PMID 11141242 DOI: 10.1097/00042560-200012150-00007 |
0.597 |
|
| 2000 |
Gisolf EH, Enting RH, Jurriaans S, de Wolf F, van der Ende ME, Hoetelmans RM, Portegies P, Danner SA. Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine. Aids (London, England). 14: 1583-9. PMID 10983645 DOI: 10.1097/00002030-200007280-00014 |
0.476 |
|
| 2000 |
van Praag RM, Weverling GJ, Portegies P, Jurriaans S, Zhou XJ, Turner-Foisy ML, Sommadossi JP, Burger DM, Lange JM, Hoetelmans RM, Prins JM. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. Aids (London, England). 14: 1187-94. PMID 10894283 DOI: 10.1097/00002030-200006160-00016 |
0.374 |
|
| 2000 |
Portegies P, Corssmit N. Epstein-Barr virus and the nervous system. Current Opinion in Neurology. 13: 301-4. PMID 10871255 DOI: 10.1097/00019052-200006000-00012 |
0.322 |
|
| 2000 |
Enting RH, Portegies P. Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy. Journal of Neurology. 247: 134-8. PMID 10751117 DOI: 10.1007/Pl00007794 |
0.373 |
|
| 2000 |
Enting RH, Foudraine NA, Lange JM, Jurriaans S, van der Poll T, Weverling GJ, Portegies P. Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine. Journal of Neuroimmunology. 102: 216-21. PMID 10636491 DOI: 10.1016/S0165-5728(99)00219-2 |
0.42 |
|
| 1999 |
van Rij RP, Portegies P, Hallaby T, Lange JM, Visser J, de Roda Husman AM, van 't Wout AB, Schuitemaker H. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. The Journal of Infectious Diseases. 180: 854-7. PMID 10438379 DOI: 10.1086/314940 |
0.495 |
|
| 1999 |
Boven LA, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet HS. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. Journal of Immunology (Baltimore, Md. : 1950). 162: 4319-27. PMID 10201964 |
0.327 |
|
| 1998 |
Foudraine NA, Hoetelmans RM, Lange JM, de Wolf F, van Benthem BH, Maas JJ, Keet IP, Portegies P. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet. 351: 1547-51. PMID 10326538 DOI: 10.1016/S0140-6736(98)07333-4 |
0.435 |
|
| 1998 |
Claus JJ, Portegies P. Reversible blindness in AIDS-related cryptococcal meningitis. Clinical Neurology and Neurosurgery. 100: 51-2. PMID 9637206 DOI: 10.1016/S0303-8467(97)00119-4 |
0.317 |
|
| 1998 |
Portegies P, Rosenberg NR. Aids dementia complex: Diagnosis and drug treatment options Cns Drugs. 9: 31-40. DOI: 10.2165/00023210-199809010-00004 |
0.438 |
|
| 1997 |
Burger DM, Boucher CA, Meenhorst PL, Kraayeveld CL, Portegies P, Mulder JW, Hoetelmans RM, Beijnen JH. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier. Antiviral Therapy. 2: 113-7. PMID 11322275 |
0.399 |
|
| 1997 |
Corssmit EP, Leverstein-van Hall MA, Portegies P, Bakker P. Severe neurological complications in association with Epstein-Barr virus infection. Journal of Neurovirology. 3: 460-4. PMID 9475119 DOI: 10.3109/13550289709031193 |
0.327 |
|
| 1996 |
Portegies P, Danner SA, Enting RH, Meilof J, de Wolf F, Goudsmit J. Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment. Antiviral Therapy. 1: 195. PMID 11322255 |
0.495 |
|
| 1996 |
Portegies P, Enting RH. Neurology. Prions, oestrogens, PCR, and the brain. Lancet. 348: sII14. PMID 8973492 DOI: 10.1016/S0140-6736(96)98024-1 |
0.363 |
|
| 1996 |
Wientjens DP, van Gool WA, Portegies P, Jansen GH. [Spongiform encephalopathy in cattle and humans]. Nederlands Tijdschrift Voor Geneeskunde. 140: 1252-4. PMID 8700278 |
0.4 |
|
| 1996 |
Kersten MJ, Evers LM, Dellemijn PL, van den Berg H, Portegies P, Hintzen RQ, van Lier RA, von dem Borne AE, van Oers RH. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood. 87: 1985-9. PMID 8634448 DOI: 10.1182/Blood.V87.5.1985.Bloodjournal8751985 |
0.334 |
|
| 1995 |
Kuiken CL, Goudsmit J, Weiller GF, Armstrong JS, Hartman S, Portegies P, Dekker J, Cornelissen M. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. The Journal of General Virology. 76: 175-80. PMID 7844529 DOI: 10.1099/0022-1317-76-1-175 |
0.502 |
|
| 1995 |
van Gool WA, Hoogerwaard EM, Kuiper MA, Portegies P, Bolhuis PA. [Prion disease: a new class of neurodegenerative disorders]. Nederlands Tijdschrift Voor Geneeskunde. 139: 606-13. PMID 7700403 |
0.39 |
|
| 1995 |
Portegies P. Review of antiretroviral therapy in the prevention of HIV-related AIDS dementia complex (ADC). Drugs. 49: 25-31; discussion 38. PMID 7614899 DOI: 10.2165/00003495-199500491-00007 |
0.424 |
|
| 1995 |
Portegies P. HIV-1, the brain, and combination therapy. Lancet. 346: 1244-5. PMID 7475712 DOI: 10.1016/S0140-6736(95)91857-4 |
0.407 |
|
| 1994 |
Schot LJ, Devriese PP, Hadderingh RJ, Portegies P, Enting RH. Facial palsy and human immunodeficiency virus infection. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. S498-500. PMID 10774434 DOI: 10.1007/978-3-642-85090-5_197 |
0.326 |
|
| 1994 |
Enting RH, Esselink RA, Portegies P. Lymphomatous meningitis in AIDS-related systemic non-Hodgkin's lymphoma: a report of eight cases. Journal of Neurology, Neurosurgery, and Psychiatry. 57: 150-3. PMID 8126496 DOI: 10.1136/Jnnp.57.2.150 |
0.334 |
|
| 1994 |
Weststrate W, Portegies P, van Crevel H. [The use of protocols in a neurological department]. Nederlands Tijdschrift Voor Geneeskunde. 138: 1579-83. PMID 8072572 |
0.54 |
|
| 1994 |
Portegies P, Enting RH. [Neurological complications of HIV infection: diagnosis and therapy]. Nederlands Tijdschrift Voor Geneeskunde. 138: 1507-12. PMID 8065469 |
0.36 |
|
| 1994 |
Portegies P. AIDS dementia complex: a review. Journal of Acquired Immune Deficiency Syndromes. 7: S38-48; discussion S. PMID 7965650 |
0.376 |
|
| 1994 |
Portegies P, Enting RH, de Jong MD, Danner SA, Reiss P, Goudsmit J, Lange JM. AIDS dementia complex and didanosine. Lancet. 344: 759. PMID 7915809 DOI: 10.1016/S0140-6736(94)92252-7 |
0.475 |
|
| 1993 |
Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, Goudsmit J. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. Aids (London, England). 7: 669-75. PMID 8318174 DOI: 10.1097/00002030-199305000-00010 |
0.604 |
|
| 1993 |
Portegies P, Godfried MH, Hintzen RQ, Stam J, van der Poll T, Bakker M, van Deventer SJ, van Lier RA, Goudsmit J. Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex. Journal of Neuroimmunology. 48: 241-7. PMID 8227320 DOI: 10.1016/0165-5728(93)90198-8 |
0.648 |
|
| 1993 |
Esselink R, Enting R, Portegies P. Low frequency of neurosyphilis in HIV-infected individuals. Lancet. 341: 571. PMID 8094824 DOI: 10.1016/0140-6736(93)90345-H |
0.419 |
|
| 1992 |
Enting RH, Portegies P, Algra PR, Valk J, Lange JM. [Progressive multifocal leukoencephalopathy in AIDS]. Nederlands Tijdschrift Voor Geneeskunde. 136: 521-6. PMID 1552955 |
0.318 |
|
| 1992 |
Enting R, de Gans J, Reiss P, Jansen C, Portegies P. Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS. Lancet. 340: 559-60. PMID 1354319 DOI: 10.1016/0140-6736(92)91764-Y |
0.306 |
|
| 1992 |
Enting RH, Portegies P, Vermeulen M. [Neuropathies in the course of HIV infection]. Nederlands Tijdschrift Voor Geneeskunde. 136: 2361-5. PMID 1334234 |
0.359 |
|
| 1992 |
Enting RH, Portegies P, de Visser M. [Myopathies in the course of HIV infection]. Nederlands Tijdschrift Voor Geneeskunde. 136: 1446-9. PMID 1331819 |
0.357 |
|
| 1992 |
de Gans J, Portegies P, Tiessens G, Eeftinck Schattenkerk JK, van Boxtel CJ, van Ketel RJ, Stam J. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. Aids (London, England). 6: 185-90. PMID 1313682 DOI: 10.1097/00002030-199202000-00007 |
0.361 |
|
| 1991 |
Portegies P, Goudsmit J. [Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy]. Nederlands Tijdschrift Voor Geneeskunde. 135: 1302-6. PMID 1865933 |
0.371 |
|
| 1991 |
Portegies P, Brew BJ. Update on HIV-related neurological illness. Aids (London, England). 5: S211-7. PMID 1845050 DOI: 10.1097/00002030-199101001-00029 |
0.445 |
|
| 1990 |
Portegies P. [The neurological and neuropsychological status of HIV-seropositive persons without symptoms]. Nederlands Tijdschrift Voor Geneeskunde. 134: 1292-3. PMID 2374613 |
0.304 |
|
| 1990 |
de Gans J, Tiessens G, Portegies P, Tutuarima JA, Troost D. Predominance of polymorphonuclear leukocytes in cerebrospinal fluid of AIDS patients with cytomegalovirus polyradiculomyelitis. Journal of Acquired Immune Deficiency Syndromes. 3: 1155-8. PMID 2173744 |
0.401 |
|
| 1990 |
Derix MM, de Gans J, Stam J, Portegies P. Mental changes in patients with AIDS. Clinical Neurology and Neurosurgery. 92: 215-22. PMID 2171828 DOI: 10.1016/0303-8467(90)90023-X |
0.589 |
|
| 1990 |
de Gans J, Portegies P, Tiessens G, Troost D, Danner SA, Lange JM. Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir. Aids (London, England). 4: 421-5. PMID 2164819 DOI: 10.1097/00002030-199005000-00007 |
0.368 |
|
| 1990 |
Sillevis Smitt PA, Portegies P. Fisher's syndrome associated with human immunodeficiency virus infection. Clinical Neurology and Neurosurgery. 92: 353-5. PMID 1963828 DOI: 10.1016/0303-8467(90)90064-C |
0.438 |
|
| 1989 |
Portegies P, Epstein LG, Hung ST, de Gans J, Goudsmit J. Human immunodeficiency virus type 1 antigen in cerebrospinal fluid. Correlation with clinical neurologic status. Archives of Neurology. 46: 261-4. PMID 2919978 DOI: 10.1001/Archneur.1989.00520390027010 |
0.597 |
|
| 1989 |
de Gans J, Portegies P. Neurological complications of infection with human immunodeficiency virus type 1. A review of literature and 241 cases. Clinical Neurology and Neurosurgery. 91: 199-219. PMID 2548785 DOI: 10.1016/0303-8467(89)90114-5 |
0.307 |
|
| 1989 |
Portegies P, de Gans J, Lange JM, Derix MM, Speelman H, Bakker M, Danner SA, Goudsmit J. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Bmj (Clinical Research Ed.). 299: 819-21. PMID 2510843 DOI: 10.1136/Bmj.299.6703.819 |
0.603 |
|
| 1989 |
Portegies P, Epstein LG, Tjong S, Hung A, De Gans J, Goudsmit J. Cerebrospinal fluid investigations in HIV-1 infection Journal of Clinical Chemistry and Clinical Biochemistry. 27: 905. |
0.376 |
|
| 1988 |
de Gans J, Portegies P, Derix MM, Troost D, Valk J, Goudsmit J. [The AIDS-dementia complex: primary infection by human immunodeficiency virus type I]. Nederlands Tijdschrift Voor Geneeskunde. 132: 1570-5. PMID 3173530 |
0.467 |
|
| Show low-probability matches. |